Typ : |
Noviny |
Internetový odkaz : |
https://doi.org/10.1007/s40268-023-00433-7 |
|
Výzkumné týmy : |
Incheon - Quality Evaluation Team, Samsung Bioepis Co |
Autor : |
Tak M, Jeong H, Yun J, Kim J, Kim S, Lee Y, Park S-J. |
Titul : |
In‑Use Stability of SB12 (Eculizumab, Soliris Biosimilar) Diluted in Saline and Dextrose Infusion Solution after an Extended Storage Period. |
Référence : |
Drugs R D ;23,4:363 - 375 2023 |
|
Úroveň důkazu : |
|
Fyzikální stabilita : |
|
Chemická stabilita : |
|
Jiné metody : |
|
Komentáře : |
Bílkoviny: biologická aktivita enzymatické techniky |
|
Seznamy
Eculizumab
|
|
|
|
|
|
|
|
|
|
5 mg/ml |
2-8°C |
|
90 |
|
|
|
|
|
|
5 mg/ml |
28-32°C |
|
72 |
|
|
|
|
|
|
5 mg/ml |
2-8°C |
|
90 |
|
|
|
|
|
|
5 mg/ml |
28-32°C |
|
72 |
|
|
|
|
|
|
5 mg/ml |
2-8°C |
|
90 |
|
|
|
|
|
|
5 mg/ml |
28-32°C |
|
72 |
|
|
|
|
|
|
5 mg/ml |
2-8°C |
|
90 |
|
|
|
|
|
|
5 mg/ml |
28-32°C |
|
72 |
|
|
|
|
|